156 related articles for article (PubMed ID: 30515847)
1. Response of hepatitis B virus to antiretroviral treatment containing lamivudine in HBsAg-positive and HBsAg-negative HIV-positive South African adults.
Singh L; Bell TG; Yousif M; Kramvis A
J Med Virol; 2019 May; 91(5):758-764. PubMed ID: 30515847
[TBL] [Abstract][Full Text] [Related]
2. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program.
Hoffmann CJ; Charalambous S; Martin DJ; Innes C; Churchyard GJ; Chaisson RE; Grant AD; Fielding KL; Thio CL
Clin Infect Dis; 2008 Dec; 47(11):1479-85. PubMed ID: 18937580
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana.
Chadwick D; Ankcorn M; Sarfo F; Phillips R; Fox Z; Garcia A; Appiah L; Bedu-Addo G; Geretti AM
J Antimicrob Chemother; 2012 Dec; 67(12):2939-42. PubMed ID: 22915461
[TBL] [Abstract][Full Text] [Related]
5. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ
J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.
Ocama P; Seremba E; Apica B; Opio K
Afr Health Sci; 2015 Jun; 15(2):328-33. PubMed ID: 26124776
[TBL] [Abstract][Full Text] [Related]
7. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations.
Sucupira MV; Mello FC; Santos EA; Niel C; Rolla VC; Arabe J; Gomes SA
Mem Inst Oswaldo Cruz; 2006 Sep; 101(6):655-60. PubMed ID: 17072479
[TBL] [Abstract][Full Text] [Related]
8. New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.
Dunn D; Price H; Vudriko T; Kityo C; Musoro G; Hakim J; Gilks C; Kaleebu P; Pillay D; Gilson R;
J Acquir Immune Defic Syndr; 2021 Jan; 86(1):98-103. PubMed ID: 33306565
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Boyd A; Maylin S; Moh R; Mahjoub N; Gabillard D; Eholié SP; Danel C; Anglaret X; Zoulim F; Girard PM; Delaugerre C; Lacombefor K;
J Gastroenterol Hepatol; 2016 Mar; 31(3):634-44. PubMed ID: 26313291
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence.
Bivigou-Mboumba B; Amougou-Atsama M; Zoa-Assoumou S; M'boyis Kamdem H; Nzengui-Nzengui GF; Ndojyi-Mbiguino A; Njouom R; François-Souquière S
PLoS One; 2018; 13(1):e0190592. PubMed ID: 29315352
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.
Wandeler G; Musukuma K; Zürcher S; Vinikoor MJ; Llenas-García J; Aly MM; Mulenga L; Chi BH; Ehmer J; Hobbins MA; Bolton-Moore C; Hoffmann CJ; Egger M;
PLoS One; 2016; 11(3):e0152043. PubMed ID: 27032097
[TBL] [Abstract][Full Text] [Related]
12. The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.
Mitsumoto F; Murata M; Ura K; Takayama K; Hiramine S; Shimizu M; Toyoda K; Ogawa E; Furusyo N; Hayashi J
J Infect Chemother; 2015 Apr; 21(4):264-71. PubMed ID: 25596071
[TBL] [Abstract][Full Text] [Related]
13. Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.
Huang YS; Chang SY; Sheng WH; Sun HY; Lee KY; Chuang YC; Su YC; Liu WC; Hung CC; Chang SC
PLoS One; 2016; 11(12):e0169228. PubMed ID: 28033344
[TBL] [Abstract][Full Text] [Related]
14. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
Liégeois F; Boyer S; Eymard-Duvernay S; Carrieri P; Kouanfack C; Domyeum J; Maradan G; Ducos J; Mpoudi-Ngolé E; Spire B; Delaporte E; Kuaban C; Vidal L; Laurent C;
BMC Infect Dis; 2020 Jan; 20(1):49. PubMed ID: 31941464
[TBL] [Abstract][Full Text] [Related]
16. Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans.
Lukhwareni A; Gededzha MP; Amponsah-Dacosta E; Blackard JT; Burnett RJ; Selabe SG; Kyaw T; Mphahlele MJ
Viruses; 2020 Jun; 12(6):. PubMed ID: 32545313
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of hepatitis B virus diagnostic methods and responses to antiretroviral therapy among HIV-infected women in Thailand.
Peters PJ; McNicholl JM; Raengsakulrach B; Wasinrapee P; Mueanpai F; Ratanasuwan W; Intalapaporn P; Drobeniuc J; Ramachandran S; Thai H; Xia GL; Kamili S; Khudyakov Y; Weidle PJ; Teo CG; McConnell MS
J Int Assoc Provid AIDS Care; 2013; 12(5):349-53. PubMed ID: 23792710
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
[TBL] [Abstract][Full Text] [Related]
19. Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China.
Gu L; Han Y; Li Y; Zhu T; Song X; Huang Y; Yang F; Guan S; Xie J; Gohda J; Hosoya N; Kawana-Tachikawa A; Liu W; Gao GF; Iwamoto A; Li T; Ishida T
PLoS One; 2015; 10(8):e0134539. PubMed ID: 26288093
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of HBV infection in a cohort of Ugandan HIV-infected patients and rate and pattern of lamivudine-resistant HBV infection in patients receiving antiretroviral therapy.
Calisti G; Muhindo R; Boum Y; Wilson LA; Foster GM; Geretti AM; Bhagani S
Trans R Soc Trop Med Hyg; 2015 Nov; 109(11):723-9. PubMed ID: 26386408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
